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Perceived decline in cognition in the absence of
what is commonly termed ‘objective evidence’ is fre-
quently referred to as subjective cognitive decline
(SCD). While etiologically heterogeneous and there-
fore potentially responsive to intervention in some
cases, SCD remains primarily associated with an
increased risk of developing dementia. It is becom-
ing clear however that, irrespective of cause, SCD can
have a detrimental effect upon quality of life. Although
there is increasing interest in SCD within both research
and clinical arenas, it remains a topic that provokes sub-
stantial debate particularly with regard to its definition,
diagnosis, and management.
The aim of this supplemental issue of the Journal
of Alzheimer’s Disease is to bring together some of
these controversial areas of discussion in order to pro-
mote future debate and collaborative research about
SCD and to encourage greater unity of approach. Con-
sequently, the content of the articles presented here is
varied and includes reviews, audits, perspectives, con-
cepts, models, and research papers using qualitative
and quantitative research methodologies.
Starting with a conceptual paper, Stone and
colleagues [1] illustrate how SCD can arise from a
range of ‘functional’ disorders, as well as in some cases
being a harbinger of neurodegenerative dementia, and
highlight the importance of correct classification.
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Moving on to audits, Pennington and colleagues [2]
highlight and discuss the fact that functional memory
disorders are common in neurology memory services;
that patients with functional symptoms are not only
the worried well or just suffering from anxiety and
depression, and that there can be significant social
and occupational impairment. Of particular relevance
to memory clinics and services is the qualitative ser-
vice evaluation performed by Jenkins and colleagues
[3] to determine the state of knowledge of SCD and
what actions are taken for its management in specialist
clinical practice in the UK at the present time.
Related to the potential real life impact of SCD is the
finding by Luck and colleagues [4] of a significantly
increased mortality risk in non-demented elderly peo-
ple with SCD. This highlights the importance of taking
SCD seriously in clinical practice not only in relation
to an increased risk of developing dementia but also for
a broader range of possible adverse health outcomes,
one of which may be mortality.
In terms of assessment, Tandetnik and colleagues [5]
highlight how variability in assessment method, specif-
ically the manner in which questions and response
options are phrased, plays an important role in deter-
mining rates of SCD. Also related to assessment is
Della Barba and colleagues’ [6] model suggesting
that the neuropsychological assessment of memory
performance should always be coupled with a deep
evaluation of awareness of the individual’s memory
profile. An in-depth review by Rabin and colleagues [7]
describes the self-report measures currently employed
by 19 international sites and calls for international
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collaboration to promote harmonization and pooling
of cognitive self-report data. Valech and colleagues [8]
describe a study in which they found that informants’
ratings of cognitive decline were able to differentiate
pre-Alzheimer’s disease (AD) subjects from controls
and that informants’ ratings also correlated signifi-
cantly with AD biomarkers. Rodrı´guez-Go´mez and
colleagues [9] show that the setting in which the study
is conducted affects key characteristics of the sample
such as age, educational level, or family history and
discuss the paucity of studies that specifically test the
influence of sampling and recruitment methods in this
area of research.
On the topic of etiology, Archer and colleagues [10]
describe how SCD in some individuals will result from
mood disorders/personality factors or systemic illness;
evaluating how individuals are defined within different
research settings, their rates of progression to mild cog-
nitive impairment and dementia, and how individuals
within these contexts differ in terms of complaints, per-
sonal characteristics, and help seeking behavior. Also
related to the issue of mood disorders is the study
by Yates and colleagues [11], who, using structured
interviews with community dwelling older people to
collect information regarding cognitive functioning,
mood, and wellbeing, reveal that subjective memory
complaints are more likely to be related to mood prob-
lems than objective cognitive impairment. Continuing
this theme, Buckley and colleagues [12] describe how
that although the presence of SCD is acknowledged
as a risk factor of future dementia, few studies have
attempted to capture the qualitative perspective of this
phenomenological experience, pointing out that such
a perspective is often central to clinical diagnostics,
and therefore potentially of use in determining the
underlying cause of SCD.
A neuroimaging study by Perrotin and colleagues
[13] investigates hippocampal subfields for the first
time in SCD using individual subfield delineation
together with 3D hippocampal surface projection
of grey matter atrophy maps and demonstrate that
patients with SCD show a differential pattern of
atrophy of the hippocampal subfields mimicking that
found in AD. A further study by Snitz and colleagues
[14] reveals that older adults presenting to a memory
clinic with concerns about their cognition, but testing
within normal limits on objective evaluation, show
measurable deviations on standardized scales of
subjective cognition and negative affect and increased
A deposition on PiB-PET imaging compared with
age-matched healthy controls recruited from the
community.
Using a computer-based test, Koppara and col-
leagues [15] provide evidence for specific visual short
term memory binding deficits in individuals with SCD
and suggest that the results show that a feature binding
test can help to objectify deficits in SCD which are not
detectable with an established neuropsychological test
battery.
Finally, Lista and colleagues [16] provide a com-
prehensive review addressing current perspectives and
the way forward in SCD with emphasis on the issues
of biomarkers.
The wide range of topics included in this special
issue highlights how taking a ‘division of labor’
approach, i.e., by asking questions about a wide range
of brain functions and behavior and using multi-
modal techniques to answer them, can significantly
increase our understanding of this controversial and
undeniably complex disorder. Although preliminary
research into AD and mild cognitive impairment was
typically limited to investigating a relatively narrow
range of brain functions and behavior, mainly those
assessed as part of clinical diagnosis, later research
revealed that many more aspects and levels of brain
function and information processing can be detri-
mentally affected. Already the findings included in
this issue emphasize the importance of this approach,
i.e., of asking new questions and finding answers
by using multiple methodologies, in significantly
improving our understanding of subjective cognitive
impairment.
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